Public Employees Retirement Association of Colorado boosted its position in shares of CME Group Inc (NASDAQ:CME) by 5.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 63,436 shares of the financial services provider’s stock after purchasing an additional 3,376 shares during the period. Public Employees Retirement Association of Colorado’s holdings in CME Group were worth $9,265,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CME. Quadrant Capital Group LLC boosted its position in CME Group by 13.6% during the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after purchasing an additional 113 shares during the last quarter. Valeo Financial Advisors LLC acquired a new stake in CME Group during the third quarter valued at $124,000. Bank of Nova Scotia Trust Co. acquired a new stake in CME Group during the third quarter valued at $165,000. SeaCrest Wealth Management LLC acquired a new stake in CME Group during the fourth quarter valued at $203,000. Finally, LaFleur & Godfrey LLC acquired a new stake in CME Group during the third quarter valued at $204,000. 82.65% of the stock is owned by hedge funds and other institutional investors.
In other news, insider Sunil Cutinho sold 2,600 shares of CME Group stock in a transaction dated Friday, November 17th. The stock was sold at an average price of $139.57, for a total value of $362,882.00. Following the transaction, the insider now directly owns 22,301 shares in the company, valued at $3,112,550.57. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Leo Melamed sold 7,300 shares of CME Group stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $155.78, for a total value of $1,137,194.00. Following the completion of the transaction, the director now owns 10,537 shares in the company, valued at $1,641,453.86. The disclosure for this sale can be found here. Insiders sold 47,128 shares of company stock worth $7,052,957 over the last quarter. 0.57% of the stock is currently owned by corporate insiders.
CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.02. CME Group had a return on equity of 7.68% and a net margin of 111.49%. The company had revenue of $900.00 million during the quarter, compared to analysts’ expectations of $886.85 million. During the same quarter in the previous year, the firm earned $1.14 earnings per share. The business’s quarterly revenue was down 1.4% compared to the same quarter last year. sell-side analysts expect that CME Group Inc will post 6.26 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Monday, March 26th. Shareholders of record on Friday, March 9th will be given a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.75%. This is a boost from CME Group’s previous quarterly dividend of $0.66. CME Group’s payout ratio is currently 22.11%.
CME has been the subject of a number of research reports. Bank of America lifted their price objective on CME Group from $173.00 to $175.00 and gave the company a “buy” rating in a research report on Friday, February 2nd. Citigroup lifted their price objective on CME Group from $138.00 to $155.00 and gave the company a “buy” rating in a research report on Thursday, October 19th. BidaskClub cut CME Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, October 18th. Zacks Investment Research raised CME Group from a “hold” rating to a “buy” rating and set a $164.00 price target for the company in a research report on Tuesday, January 2nd. Finally, Sandler O’Neill reaffirmed a “buy” rating and issued a $175.00 price target on shares of CME Group in a research report on Friday, February 2nd. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. CME Group has a consensus rating of “Buy” and a consensus price target of $157.00.
ILLEGAL ACTIVITY NOTICE: This report was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another domain, it was stolen and republished in violation of international copyright law. The original version of this report can be read at https://www.com-unik.info/2018/02/08/public-employees-retirement-association-of-colorado-grows-position-in-cme-group-inc-cme.html.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.